Journal
CELLULAR SIGNALLING
Volume 25, Issue 12, Pages 2788-2796Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2013.09.009
Keywords
Diabetic nephropathy; TXNIP; ROS; EMT; TCF-beta 1
Categories
Funding
- National Natural Science Foundation of China [81170673, 81270804]
- Doctoral Program of Higher Education [20091323120001]
- Hebei Provincial Natural Science Fund [C2011206147]
- Key Project of Hebei Education Department [ZD200906, 2010134]
Ask authors/readers for more resources
Epithelial to mesenchymal transition (EMT) of tubular cells contributes to the renal accumulation of matrix protein that is associated with diabetic nephropathy. Both high glucose and transforming growth factor-beta (TGF-beta) are able to induce EMT in cell culture. In this study, we examined the role of the thioredoxin-interacting protein (TXNIP) on EMT induced by high glucose or TGF-beta 1 in HK-2 cells. EMT was assessed by the expression of alpha-smooth muscle actin (alpha-SMA) and E-cadherin and the induction of a myofibroblastic phenotype. High glucose (30 mM) was shown to induce EMT at 72 h. This was blocked by knockdown of TXNIP or antioxidant NAC. Meanwhile, we also found that knockdown of TXNIP or antioxidant NAC inhibited high glucose-induced generation of reactive oxygen species (ROS), phosphorylation of p38 MAPK and ERK1/2 and expression of TGF-beta 1. HK-2 cells that were exposed to TGF-beta 1 (4 ng/ml) also underwent EMT. The expression of TXNIP gene and protein was increased in HK-2 cells treated with TGF-beta 1. Transfection with TXNIP shRNA was able to attenuate TGF-beta 1 induced-EMT. These results suggested that knockdown of TXNIP antagonized high glucose-induced EMT by inhibiting ROS production, activation of p38 MAPK and ERK1/2, and expression of TGF-beta 1, highlighting TXNIP as a potential therapy target for diabetic nephropathy. (C) 2013 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available